James Woys, the Chief Operating Officer of Molina Healthcare, Inc. (NYSE:MOH), has sold a significant portion of his company stock, according to a recent filing with the Securities and Exchange Commission. The transaction, which took place on May 22, involved the sale of shares at prices ranging from $343.02 to $347.93.
The total value of the shares sold by Woys amounted to approximately $3,451,480. The sale was executed under a Rule 10b5-1 trading plan, which was established on February 20, 2024. Such plans allow company insiders to sell shares at predetermined times to avoid accusations of trading on nonpublic information.
Woys' transactions included multiple sales at varying prices within a one-dollar range, indicating a volume-weighted average selling price for each batch of shares. The specific number of shares sold at each price point within the range can be provided upon request by the Commission staff, as noted in the filing's footnotes.
The sale has resulted in a decrease in Woys' direct ownership of Molina Healthcare stock, although the exact number of shares he retains following the transaction was not specified in the summary provided. The filing was signed on Woys' behalf by Jeff D. Barlow, pursuant to the power of attorney for James Woys.
Molina Healthcare, based in Long Beach, California, operates in the hospital and medical service plans industry. The company's shares are publicly traded on the New York Stock Exchange under the ticker symbol MOH.
InvestingPro Insights
In light of the recent stock sale by James Woys, Chief Operating Officer of Molina Healthcare, Inc. (NYSE:MOH), it's pertinent for investors to consider the company's financial health and market performance. InvestingPro data provides a snapshot of Molina Healthcare's current market position:
- The company holds a Market Cap of approximately 19.45B USD, reflecting its significant presence in the healthcare industry.
- Molina Healthcare is currently trading at a P/E Ratio of 18.08, and when adjusted for the last twelve months as of Q1 2024, the P/E Ratio is slightly lower at 17.6.
- Revenue Growth for the last twelve months as of Q1 2024 stood at 9.98%, with a more robust quarterly growth rate of 20.77% for Q1 2024.
Furthermore, two InvestingPro Tips can offer additional insights:
- Molina Healthcare is recognized as a prominent player in the Healthcare Providers & Services industry, which may provide stability and growth potential.
- The company is trading at a low revenue valuation multiple, suggesting that its stock could be undervalued relative to its sales.
For investors considering Molina Healthcare's stock, these metrics and InvestingPro Tips could be crucial in making an informed decision. It's also noteworthy that the company holds more cash than debt on its balance sheet, which is a strong indicator of financial stability.
For those seeking further insights, InvestingPro offers additional tips that can help you understand Molina Healthcare's financial nuances. There are 11 more InvestingPro Tips available, which can be accessed through a subscription. Use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and gain valuable insights that could guide your investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.